MAGNET - A multi-arm, adaptive, group-sequential trial network to evaluate drug efficacy in patients with Amyotrophic Lateral Sclerosis (ALS) (FightMND grant administered by USyd) (2022–2025)

Grant type:
University of Sydney
Researchers:
  • Professorial Research Fellow
    Institute for Molecular Bioscience
    Affiliate NHMRC Leadership Fellow
    Queensland Brain Institute
Funded by:
The University of Sydney